Bifidobacterium infantis and Reduced Healthcare Costs

• Clinical benefits of Bifidobacterium infantis YLGB-1496 in modulating gut microbiota and immunity in young children.

  • 2026-01-05
  • Clinical Trial
  • Frontiers in nutrition 12
  • • Mageswaran Uma Mageswary
    • Pin Li
    • Rocky Vester Richmond
    • Yusof Azianey
    • Intan Juliana Abd Hamid
    • Fahisham Taib
    • Min-Tze Liong
    • Adli Ali
    • Joo Shun Tan
    • Yumei Zhang

  • PubMed: 41561177
  • DOI: 10.3389/fnut.2025.1713135

  5 Insights on

  • Reduced Healthcare Costs

  • Moderate evidence

  alongside fewer clinical visits and antibiotic prescriptions (p < 0.01 for all)

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes